Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ascendis Pharma A/s (ASND)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Vivo Capital

Albert Cha And Frank Kung

2,166,832 $135,752 17.33%
2.
RA Capital Management

Peter Kolchinsky

4,240,536 $265,670 15.46%
3.
VenBio Select Advisor

Kurt Von Emster

1,980,000 $124,047 +1% 7.41%
4.
OrbiMed Advisors

Samuel Isaly

4,087,373 $256,074 -2% 4.73%
5.
EcoR1 Capital

Oleg Nodelman

679,746 $42,586 -38% 4.26%
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 504,210 $31,589 13.56%
2. 1,498,538 $93,883 11.69%
3. 245,424 $15,376 7.05%
4. 1,698,648 $106,420 4.71%
5. 204,088 $12,786 4.19%
News See All